Jaume Amat

CEO & Co-Founder — Rob Surgical

Connect

Education

  • Bachelor’s degree in Telecommunications Engineering, Ramon Llull University-La Salle
  • PDD, IESE
  • Leadership Program, Auckland Business School

Biography

Since 2000, Jaume has been involved in the creation of several companies in the field of biomedicine such as Goodgut (acquired by Hipra), Aniling, VCN Biosciences (acquired by Grifols), Archivel Farma, among others.

Currently, he is CEO of Rob Surgical and chairman of the Board of Specipig.

He is former president of the CataloniaBio & HealthTech business association.

BHV Partners - Jaume Amat